Chinese regulatory authorities have granted Boehringer Ingelheim Vetmedica GmbH market authorization for ingelvac CircoFLEX, a vaccine against porcine circovirus disease. The vaccine contains a purified circo-antigen with ImpranFLEX adjuvant. It is licensed as a single-shot vaccine recommended for administration around weaning. The vaccine was previously approved for use in North America, Europe, Australia, South Africa and parts of South America and Asia.
Boehringer Ingelheim Vetmedica ingelvac CircoFLEX vaccine
Fill out the form below to request more information about Boehringer Ingelheim Vetmedica ingelvac CircoFLEX vaccine
More From Boehringer Ingelheim Vetmedica Inc.